thiazolidines has been researched along with Liver Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, M; Alsalim, TA; El-Arabey, AA; Nasir, NM | 1 |
| Akahane, T; Fujinaga, Y; Furukawa, M; Kaji, K; Kawaratani, H; Kaya, D; Kitade, M; Kitagawa, K; Mitoro, A; Moriya, K; Nakanishi, K; Namisaki, T; Noguchi, R; Ozutsumi, T; Saikawa, S; Sato, S; Sawada, Y; Shimozato, N; Takaya, H; Tsuji, Y; Yoshiji, H | 1 |
| Anderson, JC; Aye, JM; Beierle, EA; Bownes, LV; Marayati, R; Quinn, CH; Stafman, LL; Stewart, JE; Willey, CD; Williams, AP; Yoon, KJ | 1 |
| Aucher, A; Davis, DM; Rudnicka, D | 1 |
| Badawi, A; Brauss, T; Doller, A; Eberhardt, W; Pfeilschifter, J; Piiper, A; Pleli, T; Schmid, T; zu Heringdorf, DM | 1 |
| Cheng, Y; Fu, DZ; He, H; Liu, HY; Liu, YF | 1 |
| Awad, HM; El-Sayed, WA; El-Sofany, WI; Flefel, EM; Mohamed, AM | 1 |
| Murata, K; Sakamoto, A | 1 |
| Gong, P; Lv, Y; Wang, S; Zhang, G; Zhang, N; Zhao, Y | 1 |
| Alonso-Varona, A; Bilbao, P; Calle, Y; Castro, B; del Olmo, M; Palomares, T | 1 |
| Harding, S; Rosado, JA; Rosenzweig, I; Sage, SO | 1 |
| Li, S; Niu, B; Wang, M; Wang, Z; Yu, Y; Zeng, S | 1 |
12 other study(ies) available for thiazolidines and Liver Neoplasms
| Article | Year |
|---|---|
Anticancer, antioxidant activities and molecular docking study of thiazolidine-4-one and thiadiazol derivatives.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Endothelial Cells; Humans; Liver Neoplasms; Molecular Docking Simulation; Molecular Structure; Reactive Oxygen Species; Structure-Activity Relationship; Thiazolidines; Tumor Microenvironment | 2023 |
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Topics: Animals; Cadherins; Canagliflozin; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; Collagen Type I; Collagen Type I, alpha 1 Chain; Cytokines; Disease Progression; DNA Damage; Drug Synergism; Hepatic Stellate Cells; Human Umbilical Vein Endothelial Cells; Humans; Lipid Peroxidation; Liver Cirrhosis; Liver Neoplasms; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Pyrazoles; Rats; Rats, Inbred Strains; Thiazolidines; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2020 |
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression; Hepatoblastoma; Humans; Liver Neoplasms; Mice; Neoplastic Stem Cells; Phenotype; Proto-Oncogene Proteins c-pim-1; Thiazolidines; Xenograft Model Antitumor Assays | 2021 |
MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Communication; Cell Division; Cell Line, Transformed; Cell Line, Tumor; Cell-Derived Microparticles; Coculture Techniques; Cytoskeleton; Exosomes; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hep G2 Cells; Humans; Leukemia, Monocytic, Acute; Liver Neoplasms; Macrophages; Mastocytoma; MicroRNAs; Receptor, IGF Type 1; Recombinant Fusion Proteins; RNA, Small Interfering; Stathmin; Thiazolidines; Transfection | 2013 |
The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR trafficking.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cyclin A; Cyclin D; Cyclooxygenase 2; Cytoskeleton; Dinoprostone; ELAV Proteins; Hep G2 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Neoplasms; Nonmuscle Myosin Type IIA; Polyribosomes; Protein Transport; Ribonucleoproteins; RNA, Messenger; Thiazolidines | 2015 |
Recombinant human PDCD5 exhibits an antitumor role in hepatocellular carcinoma cells via clathrin‑dependent endocytosis.
Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Endocytosis; Female; Genetic Engineering; Humans; Liver Neoplasms; Male; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Proteins; Recombinant Fusion Proteins; Sulfonamides; Thiazolidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Colorectal Neoplasms; Glycosylation; HCT116 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Male; Prostatic Neoplasms; Spiro Compounds; Structure-Activity Relationship; Thiadiazoles; Thiazolidines; Thioglycosides | 2017 |
Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Topics: Actins; Biomarkers; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Transdifferentiation; Clathrin; Cytoskeleton; Dose-Response Relationship, Drug; Endocytosis; Epithelial Cells; Fibroblasts; Humans; Lipoproteins, LDL; Liver Neoplasms; Protein Precursors; Prothrombin; Tetradecanoylphorbol Acetate; Thiazolidines; Vitamin K 2 | 2008 |
Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Female; Fibroblasts; Humans; Indoles; Inhibitory Concentration 50; Liver Neoplasms; Lung Neoplasms; Pyrroles; Sunitinib; Thiazolidines | 2011 |
Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
Topics: Acrolein; Alkylation; Animals; Antineoplastic Agents, Alkylating; Biotransformation; Cell Division; Cyclophosphamide; Cysteine; Disease Progression; Drug Interactions; Drug Screening Assays, Antitumor; Female; Glutathione; Leukopenia; Liver Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Prodrugs; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 2000 |
Tumor necrosis factor-alpha inhibits store-mediated Ca2+ entry in the human hepatocellular carcinoma cell line HepG2.
Topics: Actins; Atrial Natriuretic Factor; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Carcinogens; Carcinoma, Hepatocellular; Cell Compartmentation; Cytochalasin D; Cytoskeleton; Humans; Liver Neoplasms; Nucleic Acid Synthesis Inhibitors; Polymers; ras Proteins; Thapsigargin; Thiazoles; Thiazolidines; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |
Functional analysis of the CPS I upstream sequences with a cat assay.
Topics: Antineoplastic Agents; Carbamoyl-Phosphate Synthase (Ammonia); Carcinoma, Hepatocellular; Gene Expression; Humans; Liver Neoplasms; Plasmids; Regulatory Sequences, Nucleic Acid; Thiazoles; Thiazolidines; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1991 |